{"retracted":false,"update":{"timestamp":1491523200000,"doi":"10.1007/s10637-017-0455-y","type":"correction"},"doi":"10.1007/s10637-017-0438-z","journal":"Investigational New Drugs","publisher":"Springer Nature","title":"Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors"}
